Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis

Elisa Gremese, Gianfranco Ferraccioli, Barbara Tolusso, Alice Mannocci, F Bobbio Pallavicini, V Ravagnani, M Benucci, E Podestà, F Atzeni, D Biasi, Marina Manfredi, P Sarzi Puttini, B Laganà, C. Montecucco

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To find out whether a high number of auto-antibodies can increase the probability of a "good-EULAR response" and to identify the possible biomarkers of response in seropositive rheumatoid arthritis (RA) patients undergoing the B cell depletion therapy (BCDT).
Original languageEnglish
Pages (from-to)e40362-e40369
Number of pages7
JournalPLoS One
Volume7
DOIs
Publication statusPublished - 2012

Keywords

  • B cells
  • rheumatoid arthritis

Fingerprint

Dive into the research topics of 'Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis'. Together they form a unique fingerprint.

Cite this